<b><u> Notes on US HIV Market from GILD CC </u></b> Total US patients on therapy: <b>530K</b> Proportion of total on <b>Viread</b> in some form: <b>68%</b> (up from 64% one year ago) Proportion of total on <b>Truvada</b> in some form: <b>31%</b> Proportion of total on <b>Atripla</b>: <b>28%</b> Note: the above figures are for all treatment settings, while the pie chart in <a href='read_msg.asp?message_id=26915314'>#msg-26915314</a> is for the first-line setting only.